![](/img/cover-not-exists.png)
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study
Shitara, Kohei, Iwata, Hiroji, Takahashi, Shunji, Tamura, Kenji, Park, Haeseong, Modi, Shanu, Tsurutani, Junji, Kadowaki, Shigenori, Yamaguchi, Kensei, Iwasa, Satoru, Saito, Kaku, Fujisaki, Yoshihiko,Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(19)30088-9
Date:
April, 2019
File:
PDF, 317 KB
english, 2019